Matches in Nanopublications for { ?s ?p "[The frequencies of promoter methylation of p16, DAPK, CDH1, and TIMP-3 in cervical cancer were 57%, 44.9%, 52.6%, and 9%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP310043.RA7xrcHEUcbYlaOkvZrxxVnoAZ15sqL-wgDj82nj68pT0130_assertion description "[The frequencies of promoter methylation of p16, DAPK, CDH1, and TIMP-3 in cervical cancer were 57%, 44.9%, 52.6%, and 9%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310043.RA7xrcHEUcbYlaOkvZrxxVnoAZ15sqL-wgDj82nj68pT0130_provenance.
- NP666867.RA6TtlzxsD7I1noeQttCGJYXVw7PiSc2Abbo65cg3CHzo130_assertion description "[The frequencies of promoter methylation of p16, DAPK, CDH1, and TIMP-3 in cervical cancer were 57%, 44.9%, 52.6%, and 9%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666867.RA6TtlzxsD7I1noeQttCGJYXVw7PiSc2Abbo65cg3CHzo130_provenance.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion description "[The frequencies of promoter methylation of p16, DAPK, CDH1, and TIMP-3 in cervical cancer were 57%, 44.9%, 52.6%, and 9%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.